The use of streptomycin in the treatment of brucellosis revealed that most of the patients failed to respond satisfactorily to its administration, and among those who did respond, relapses almost always followed (1). It was subsequently observed that when sulfadiazine was given simultaneously with streptomycin, the result was much more encouraging (2-4). However, this combination was also followed by relapses (5). Brucella could be recovered after treatment from the blood of approximately 25 per cent of the patients with infections due to Br. abortus and 45 per cent of those with disease due to Br. melitensis.
Method: Solutions of streptomycin and dihydrostreptomycin were prepared by adding 10 ml. of physiologic saline solution to 1.0 gram of base of the drugs. The stock solution was stored at 40 C. and was diluted to a concentration of 1000 or 100 #ig. per ml. immediately before the sensitivity tests were performed. To each of 12 test tubes (12 X 100 mm.), except the first, was added 0.5 ml. of tryptose phosphate broth. The first two tubes were inoculated with 0.5 ml. each of the test solution of streptomycin or dihydrostreptomycin. Two-fold dilutions of the drug were made by transferring 0.5 ml. of the mixture in the second tube to the third tube, and so on, through the 11th tube. The 12th tube contained only broth and organisms. Each of the 12 tubes was then inoculated with 1.5 ml. of a 1:100 dilution of a 24-hour culture in tryptose phosphate broth. Thus, the first tube contained a 1: 4 dilution of the test solution of the antibiotic; the second, 1: 8; third, 1: 16, through the 11th, which contained a 1: 4096 dilution. The cultures of Br. abortus were incubated for 48 hours at 370 C. in an environment containing a 10 per cent concentration of carbon dioxide, while the strains of Br. suis and Br. melitensis were subjected to normal atmospheric conditions. At the end of this time, the tubes were examined for gross turbidity and the contents of each tube streaked on tryptose agar. The sensitivity of the organism was reported as the minimum concentration of streptomycin or dihydrostreptomycin required to kill all the organisms. Results: No evidence of bacterial multiplication appeared in the broth cultures containing streptomycin, while in the control tubes there was a turbid growth at the end of the first 24 hours of incubation. No viable Brucella could be recovered from the tubes containing streptomycin after three hours of incubation, whereas the control cultures contained living organisms throughout the 14 days of observation (see Tables III and IV) .
Resistance of Brucella to the Antibacterial Action of Streptomycin and Dihydrostreptomycin The rapid development of resistance of gramnegative bacilli to streptomycin has been a frequent cause of the failure of the antibiotic in the treatment of human infections. The most acceptable theory of the origin of streptomycin-resistant strains of bacteria is that they arise from innately resistant organisms normally present in small numbers in every large population of a sensitive strain (6) . The presence of naturally occurring streptomycin-resistant organisms in sensitive strains of Brucella was demonstrated by exposing Figure 2 .
Some of the streptomycin-resistant colonies were found to be largely dependent upon streptomycin for growth. The dependency of the colonies upon streptomycin was determined by adding suspensions of the colonies to pour plates with and without the addition of 100 pug. of streptomycin per ml. The resistant colonies grew equally well in the presence or absence of streptomycin, whereas the dependent colonies multiplied only in the plates containing the antibiotic. These dependent strains would grow if streaked heavily on streptomycin-free agar, but not as luxuriously as non-dependent strains. Streptomycin-dependent strains of Brucella grew equally well in the presence of dihydrostreptomycin, and strains dependent upon dihydrostreptomycin multiplied in media containing streptomycin. Media containing Survival of Variants of Brucella Suis Resistant to Streptomycin 100o000o000,000 10 ,000,000,000 1,000,000,o00 100,000,000 10,000,000 1,000,000 100,000 
Sensitizity of Strains of Brucella Isolated after Streptomycin Therapy
Streptomycin resistance as a cause of therapeutic failure in cases of brucellosis was investigated, first, by determining the sensitivity of the strains isolated after therapy as compared to the sensitivity of the strains isolated from the same patient before therapy; and, secondly, by comparing the distribution and number of the resistant variants occurring in these strains of Brucella. Fifteen strains of Brucella isolated after streptomycin therapy were tested for sensitivity to streptomycin. Seven strains of Br. abortus and six strains of Br. melitensis cultured after combined sulfadiazine and streptomycin therapy showed no change in sensitivity to streptomycin. One strain of Br. abortus obtained after treatment with only streptomycin was studied by Hall and Spink (7) and was found to have increased in resistance from 1.0 jAg. per ml. to 10,000 pg. per ml. One strain of Br. melitensis, isolated after combined streptomycin and sulfadiazine therapy, changed in sensitivity from 2.5 pg. to 50,000 pg. of streptomycin per ml.
The two strains of Brucella which developed resistance to streptomycin were studied for evidence of streptomycin dependency. The strain of Br. melitensis did not depend upon the presence of streptomycin for growth, but the resistant strain of Br. abortus contained predominantly colonies that were smaller than normal and grew on streptomycin-free agar only when a heavy inoculum was used. The growth of the small colonies was greatly enhanced by the addition of from 50 to 1,000 Jpg. of streptomycin per ml. (7) .
The number of the resistant variants present in the strains isolated to the number present in strains isolated from the same patients before therapy and to strains isolated from patients who responded satisfactorily to treatment. The streptomycin survival curve of a strain of Br. abortus (Elsted) which subsequently became resistant to streptomycin is shown in Figure 3 . There is no significant difference between this curve and that of the control strain (Lynch) which responded to therapy (Figure 1) , and, as seen in Figure 4 , the curve of the surviving resistant variants of a strain isolated after therapy is identical to the curve of the strain cultured from the same patient before therapy. In order to obtain data on the number of resistant organisms present in a large number of strains of Brucella, these strains were exposed to an arbitrary concentration of 100 Jyg. of streptomycin per ml. These studies revealed that the number of variants present in strains obtained after therapy did not vary significantly from the number of survivors present in strains isolated before therapy. The number of resistant survivors found in the cultures of Br. melitensis was greater than thek number of survivors present in strains of Br. abortus (Tables V and VI) .
Other properties of the strains of Brucella recovered from patients after the completion of streptomycin therapy were studied. There were no changes in the gross colony or growth characteristics, or were changes in cell morphology noted. There were no differences in the susceptibility of these strains to the bactericidal effect of normal human serum or convalescent brucellosis serum, nor in their sensitivity to other antibiotics. Tables VII and VIII) . Two strains of Brucella resistant to streptomycin showed no comparable increased resistance to aureomycin.
The Action of Aureomycin on Brucella
The technique of the experiment was identical to that described already for streptomycin, except that the concentrations of aureomycin employed were 1.0, 10, and 100 pg. per ml.
Results: The broth containing 1.0 pug. of aureomycin per ml. became turbid on the second day of incubation, one day later than the control. Broth turbidity developed in the tube containing 10 pg. per ml. on the fourth day, but there was no evidence of multiplication of Brucella in the broth containing 100 pg. of aureomycin per ml. Organisms were consistently recovered from the tubes containing 1.0 and 10 pg. per ml., but no Brucella were cultured from the aureomycin concentration 10 ' dilution, to the third tube; and so on, through the seventh tube in each series, to which was added 0.15 ml.
of a 10' dilution of the suspension of Brucella. Thus, the total volume in each tube was 0.5 ml., and the final concentration of aureomycin in the first series of tubes was 100 tsg. per ml., through 0.39 ,ig. per ml. in the ninth series. After incubating for 24 hours under 10 per cent carbon dioxide at 370 C., the contents of each tube were subcultured on tryptose agar, using a 4 mm. wire loop. The subcultures were incubated for 96 hours and the growth recorded from + to ++++. The experiment was performed using the serum from three normal individuals, serum from the same donors heated at 56°C. for 30 minutes, and from two patients with high agglutination titers for brucellosis. A control was performed with each experiment in which broth was substituted for the serum.
Results: In series one and two, which contained the highest concentrations of aureomycin, serum interfered with the activity of aureomycin. The bactericidal power of serum, on the other hand, was enhanced by the addition of aureomycin in proportion to the concentration of the latter. The inactivated serum had no effect in increasing the antibrucella activity of aureomycin when compared to the broth control, and convalescent brucellosis serum increased only slightly the effect of the aureomycin. The most striking antibrucella Tables XII-XV). isolate aureomycin-resistant variants of Brucella 
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ACTION OF THREE ANTIBIOTICS ON BRUCELLA present in a large bacterial population, using the method described for the isolation of streptomycinresistant variants. A further attempt was made to develop aureomycin-resistant strains of Brucella by exposing the organisms to increasing concentrations of aureomycin.
Method: A 1: 100 dilution in broth of a 24-hour culture of Br. abortus was exposed to aureomycin in concentrations from 250 -to 0.25 1kg. per ml. in the manner described for the broth dilution method of determining the sensitivity of Brucella to aureomycin. After incubating for 72 hours, the broth-aureomycin mixture in each tube was examined for turbidity and at the same time a loopful was streaked on tryptose agar. The turbid broth containing the highest concentration of aureomycin was diluted 1:100 and reexposed to aureomycin in the same manner. This procedure was repeated at 72-hour intervals, using as the inoculum in each test the broth from the preceding test containing the highest concentration of aureomycin permitting the multiplication of the bacteria.
Results: After 16 exposures of the strain of Br. abortus to aureomycin, there was no significant increase in resistance, as measured by the antibiotic necessary to inhibit growth, or by that amount necessary to kill the bacteria (see Figure   5 ).
Strains of Brucella Isolated after Aureomycin Therapy
One strain of Br. abortus and three strains of Br. melitensis isolated after aureomycin therapy were tested for sensitivity to the antibiotic. There were no changes in the sensitivity to aureomycin when compared to the sensitivity of the strain isolated from the same patient before therapy.
III. CHLOROMYCETIN
The observation by Ehrlich (10) and Gottlieb (11) that chloromycetin inhibited the growth of gram-negative organisms prompted the investigation of the action of his antibiotic against Brucella.
In vitro Sensitizity of Brucella to Chloromycetin
Twenty-five strains of Brucella, including 14 strains of Br abortus, 10 120021). The method used was that described for the determination of the sensitivity of Brucella to aureomycin. The concentration of chloromycetin required to inhibit the multiplication of the strains of Brucella tested varied from 1.56 to 6.25 pg. per ml., while the concentration required to kill the organisms was from 15.6 to 125 pg. per ml. (see Tables XVI and XVII) .
The Action of Chloromycetin on Brucella
The method used to study the action of chloromycetin on Brucella was similar to that described 
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.cessful. The methods used included the exposure of a large bacterial population to concentrations of 10, 50 and 100 jug. of chloromycetin per ml., as described for streptomycin, and the repeated exposure of four strains of Brucella to increasing concentrations of chloromycetin (see Figure 6 ).
IV. OTHER ANTIBIOTICS
Eight strains of Br. abortus and one strain of Br. suis were tested for sensitivity to amorphous penicillin and to crystalline penicillin G. The broth dilution method was used. The concentration of amorphous penicillin required to prevent the multiplication of Brucella was found to vary from 5 to 31 units per ml., while the concentration required to sterilize the cultures was from 16 to 62 units per ml. The concentration of crystalline penicillin G inhibiting growth varied from 1.0 to 62 units per ml., whereas the sterilizing concentration varied from 12.5 to 250 units per ml. Strains of Brucella resistant to streptomycin and dihydrostreptomycin could be readily produced in vitro by culturing a large bacterial population in the presence of the antibiotics, suppressing the sensitive organisms in the population and allowing the normally present resistant variants to multiply. Similar attempts to produce strains resistant to aureomycin and chloromycetin were unsuccessful. Attempts to adapt strains of Brucella to growth in the presence of high concentrations of aureomycin and chloromycetin by repeated exposure of the organisms to the antibiotics were also largely unsuccessful. One would be tempted to predict from these results that the development of resistance of Brucella in human infections to streptomycin and dihydrostreptomycin might occur rapidly and frequently, but resistance to aureomycin and chloromycetin would occur infrequently and progress very slowly.
The problem of the development of resistance of Brucella as a cause of failure in the therapy of human infections was investigated by determining the sensitivity of strains of Brucella recovered from patients after therapy. Of approximately 26 patients with bacteriologic proved brucellosis due to Br. abortus treated at the University of Minnesota Hospitals, there have been six relapses following combined sulfadiazine and streptomycin therapy, while approximately 30 of 65 patients treated in Mexico with infections due to Br. melitensis subsequently had proven bacteremia. There were two relapses out of 12 patients with infections due to Br. abortus following aureomycin therapy, while Brucella were recovered after treatment from five out of 26 patients with infections due to Br. melitensis. The clinical use of chloromycetin in brucellosis is now being studied.
Of the 13 cultures of Brucella isolated after combined streptomycin and sulfadiazine therapy, one strain of Br. melitensis showed increased resistance to streptomycin. Another strain of Br. abortus, recovered after therapy with-streptomycin alone, had marked resistance to the drug. There was no evidence of an increase in the normally present streptomycin-resistant variants in the strains which failed to respond to therapy.
ACTION OF THREE ANTIBIOTICS ON BRUCELLA
Three strains of Br. melitensis and one strain of Br. abortus, cultured from human subjects after aureomycin therapy, showed no changes in sensitivity to aureomycin.
One may conclude from these studies that the relapse of brucellosis following combined streptomycin and sulfadiazine or aureomycin therapy is rarely due to a change in the sensitivity of the bacteria to streptomycin or aureomycin. The evidence suggests that the strains cultured following therapy, with the exception of the two streptomycin-resistant strains, are identical to the strains isolated from the same patients before therapy. The most likely explanation for these therapeutic failures is that the antibiotics do not actually come into direct contact with all the Brucella harbored by the host within tissue cells, within granulomata present in the reticuloendothelial system, or within other walled-off foci (12) . These and other possibilities are now being investigated. 
